Antimetabolites: all 8,294 studies that test it
Page 73 of 83. Open to participants first (1,149), then studies with results posted, then the rest; newest registration first within each.
- Weekly TP-HDFL in the Treatment of Advanced TCCCompletedNCT00154687Phase 2
- Navelbine and Capecitabine in the Treatment of Metastatic Breast CancerCompletedNCT00153907Phase 1
- Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal CancerCompletedNCT00153881Phase 1
- Treatment of Recurrent Hepatitis C After Liver TransplantationCompletedNCT00151580Phase 3
- Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate CancerCompletedNCT00151047Phase 2
- Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerCompletedNCT00151034Phase 2
- Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric CancerCompletedNCT00150670Phase 3
- Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung CancerStatus unknownNCT00150657Phase 2
- Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis CCompletedNCT00148863Phase 2
- Capecitabine in Women With Operable Breast CancerTerminatedNCT00148720Phase 2
- Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary SiteTerminatedNCT00148135Phase 2
- Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's LymphomaCompletedNCT00147875Phase 1/2
- Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell TransplantationCompletedNCT00146614Phase 2
- Cytoxan, Epirubicin and Capecitabine in Women With Breast CancerCompletedNCT00146588Not applicable
- Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder CancerStatus unknownNCT00146276Phase 3
- Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)CompletedNCT00143975Phase 2
- D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)CompletedNCT00143702Phase 2/3
- NRTI-Sparing Pilot StudyCompletedNCT00143689Phase 4
- Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell DiseaseCompletedNCT00143572Phase 1
- Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00143065Phase 2
- Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue SarcomaCompletedNCT00142571Phase 3
- Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerCompletedNCT00142480Phase 2
- Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular CarcinomaCompletedNCT00142467Phase 2
- One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose NevirapineCompletedNCT00142337Phase 2
- Docetaxel and Capecitabine in Advanced Gastric CancerCompletedNCT00142038Phase 2
- Randomized Study for Patients With Follicular Lymphoma Needing TreatmentCompletedNCT00140569Phase 3
- Selective Dose Escalation for Esophageal CancerStatus unknownNCT00139633Phase 2
- Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139269Phase 1/2
- Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139243Phase 1/2
- Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic MelanomaTerminatedNCT00138229Phase 2
- Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsCompletedNCT00138177Phase 1
- Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic DeterminantsCompletedNCT00138060Phase 4
- High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML)CompletedNCT00136448Phase 2
- Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the BladderCompletedNCT00136175Phase 2
- Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily RegimenCompletedNCT00135369Phase 3
- Study of Gemcitabine and Vinorelbine in Soft Tissue SarcomasCompletedNCT00134641Phase 2
- COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)CompletedNCT00132899Phase 3
- Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic DisorderCompletedNCT00131339Not applicable
- Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)Status unknownNCT00131053Phase 2
- High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)Status unknownNCT00131027Phase 3
- Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic CorrelatesTerminatedNCT00130936Phase 1/2
- Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)TerminatedNCT00129948Phase 2
- A Study to Evaluate PT-523 in Patients With Refractory LeukemiaWithdrawnNCT00129558Phase 1/2
- Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early AbortionCompletedNCT00129506Phase 4
- Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)CompletedNCT00129168Phase 1/2
- Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated VasculitisTerminatedNCT00128895Phase 4
- Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00128856Phase 2
- Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer PatientsCompletedNCT00128310Phase 3
- Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial TractTerminatedNCT00127595Phase 2
- Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell TumorsStatus unknownNCT00127049Phase 2
- Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00126633Phase 2
- Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)Status unknownNCT00126321Phase 2
- A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive DisorderCompletedNCT00126282Not applicable
- Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown PrimaryStatus unknownNCT00126269Phase 3
- Clofarabine in Adult Patients With Advanced Solid TumorsCompletedNCT00125840Phase 1
- Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid TumorsCompletedNCT00125827Phase 1
- Metyrapone as Additive Treatment in Major DepressionCompletedNCT00125554Phase 2
- Tarceva and Capecitabine for Pancreatic CancerCompletedNCT00125021Phase 2
- Study of Irofulven in Patients With Hormone-refractory Prostate CancerCompletedNCT00124566Phase 2
- Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid CancerCompletedNCT00124527Phase 2
- A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast CancerCompletedNCT00124111Phase 2
- Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerCompletedNCT00123851Phase 2
- Gemcitabine and Cisplatin for Gallbladder and Biliary Tract CancerCompletedNCT00123825Phase 2
- A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric CancerCompletedNCT00123318Phase 3
- Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00122694Phase 2
- Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non RespondersTerminatedNCT00122629Phase 3
- Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis CCompletedNCT00122616Phase 3
- Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)CompletedNCT00122538Phase 2
- A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal CancerStatus unknownNCT00122291Phase 2
- The Effect of Efudex Treatment on Photoaged SkinCompletedNCT00121511Not applicable
- Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedNCT00121303Phase 3
- Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00121277Phase 1
- Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in HaitiCompletedNCT00120510Not applicable
- Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal CancerTerminatedNCT00120172Phase 2
- Chemotherapy Followed by Zevalin for Relapsed Mantle Cell LymphomaCompletedNCT00119730Phase 2
- Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00119340Phase 1/2
- Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary OriginWithdrawnNCT00119314Phase 2
- Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent OsteosarcomaCompletedNCT00119301Phase 1
- Ispinesib In Combination With Capecitabine In Patients With Solid TumorsCompletedNCT00119171Phase 1
- Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic CancerWithdrawnNCT00118300Phase 1
- Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaTerminatedNCT00118196Phase 2
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal CancerWithdrawnNCT00118105Phase 2
- A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line TherapyCompletedNCT00116909Phase 2
- Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid TumorsCompletedNCT00116896Phase 1
- Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the PancreasTerminatedNCT00116389Phase 2
- Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)CompletedNCT00116298Phase 3
- DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral TherapyCompletedNCT00116116Phase 4
- A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1CompletedNCT00115908Phase 2
- Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV TransmissionCompletedNCT00115648Phase 3
- Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate CancerCompletedNCT00115635Phase 1/2
- Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast CancerCompletedNCT00114816Phase 3
- 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT00114361Phase 3
- Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative DisordersCompletedNCT00114257Phase 1
- Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00114179Phase 2
- Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00114153Phase 1
- Imuran Dosing in Crohn's Disease StudyTerminatedNCT00113503Phase 2
- Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00112710Phase 3
- Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00112697Phase 2
- Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00112567Phase 1/2
- Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112528Phase 2